Clinical trial
HBRN: Immune Regulation and Costimulation in Natural History and Therapeutic Outcome of Chronic Hepatitis B
NCT01796457 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- HBRN: Immune Regulation and Costimulation in Natural History and Therapeutic Outcome of Chronic Hepatitis B
- Lead sponsor
- University of Pennsylvania
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- March 31, 2013
- Completion date
- December 1, 2026
- Enrollment
- 40 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.